|Study Period:||2018 - 2026|
|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The culture media market is expected to register a CAGR of 6.5 % during the forecast period.
The current COVID-19 outbreak is having a positive impact on the growth of the market, as biopharmaceutical innovators are at the forefront of in vitro research and development for the search of vaccine and antiviral. The in-vitro evaluation of vaccine and antivirals generally requires a culture media in which the targeted virus or bacteria is cultured and the response is identified. The rising focus of pharmaceutical industries on research and development is fuelling the demand for culture media. For instance, in March 2020, Dynavax Technologies and Clover Biopharmaceuticals entered into a new research collaboration to develop Clover's vaccine candidate, COVID-19 S-Trimer. The trimer is produced with the help of a rapid mammalian cell culture-based expression system developed by Clover.
The culture media market is expected to grow at high growth rate due to the increasing research and development investment by private and public companies for vaccines and drugs against microorganisms. For instance, as per Clinical Trials.gov, as of February 2020, there were around 1,126 clinical trials going on for antiviral therapeutics. These trials are mainly driven by the fact that there is an increasing burden of viral infections among populations.
As per the annual report of the companies in 2019, Johnson and Johnson invested USD 11.36 billion in research and development (R&D), whereas Roche’s R&D expense amounted to CHF 11.7 billion. The recent technological developments by the market players are also contributing to the growth of the market studied. For instance, in October 2019, Thermo Fisher Scientific launched Gibco BenchStable Media, a new cell culture media that remains stable in the room and provides a flexible alternative and reduces the dependence of researchers on cold storage without disrupting the existing workflow. However, the stringent regulatory issues for the use of animal-derived products in culture media are expected to be the restraint culture media market growth.
Scope of the Report
As per the scope of the report, culture media is a special medium or a substance that encourages the growth, support, and survival of microorganisms. The culture media market is segmented by media type (chromogenic culture media, dehydrated culture media, and prepared culture media), end user (biotechnology and pharmaceutical industry, academic institute, and other end users), and geography (North America, Europe, Asia-Pacific, Middle-East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above-mentioned segments.
|By Media Type|
|Chromogenic Culture Media|
|Dehydrated Culture Media|
|Prepared Culture Media|
|By End User|
|Biotechnology and Pharmaceutical Industry|
|Other End Users|
Key Market Trends
The Biotechnology and Pharmaceutical Industry Segment is Expected to Witness a Healthy Growth Over the Forecast Period
By end user, the biotechnology and pharmaceutical industry segment is expected to hold a significant market share in the forecast period. The major factor propelling the growth of the market includes the growing burden of infectious disease and increasing research and development initiatives by the biotechnology and pharmaceutical companies.
As per the Centers for Disease Control and Prevention (CDC), in 2018–2019, about 35.5 million people were suffering from influenza in that time frame. In June 2019, Cidara Therapeutics Inc., a biotechnology company focused on developing novel anti-infectives, reported that the company is developing CB-012, its Cloudbreak antiviral Fc-conjugate (AVC) candidate for influenza. These clinical trials are expected to increase the procurement of culture media to perform clinical tests o various drug molecules. In order to cater to the market demand, the key players are making significant developments. For instance, in October 2018, Thermo Fisher Scientific completed the acquisition of the Advanced Bioprocessing business from Becton, Dickinson, and Company. The acquisition was a part of Thermofisher’s strategy to acquire Advanced bioprocessing’s cell culture media, supplements, and feeds in order to enhance its market share. Also, in September 2019, Nucleus Biologics launched the Concierge Media Manufacturing Services to speed the time from discovery to cure by offering customization and optimization of cell culture media by providing the list of components in each media formulation. All these developments are the major factors propelling the market growth.
To understand key trends, Download Sample Report
North America is Expected to Dominate the Market in the Forecast Period
Regionally, North America holds the dominant share of the global cell culture media market. The factors attributing to the largest share are the rise in research and development investments, technological advancements associated with cell culture media, and high demand for cell culture media fuel the growth of the culture media market in this region. In North America, the pharmaceutical industry is one of the most research-intensive organizations. The industry is deeply invested in applying innovative solutions to enhance pipeline development to support improvements in patient care. The federal government (United States) is the primary source of funding in the biotechnology sector. As per the estimates of the Pharmaceutical Research and Manufacturers Association, the United States firms conducted over half the world's R&D in pharmaceuticals in 2018. Approximately 79.6 billion was invested in biopharmaceutical research and development in the United States in 2018. In addition, the market growth in the current pandemic situation is also fuelled by the federal government's research funds to support pharmaceutical companies to focus more on research and developments to strengthen their clinical development pipelines. For instance, in July 2020, Novavax and Regeneron received USD 2 billion in funding from the federal government to manufacture drugs and vaccines against COVID-19. According to the National Institute of Health data, in the fiscal year 2017, clinical research funding by the NIH was around USD 12.7 billion, and it was further increased to USD 15 billion in 2019. Moreover, most of the global manufacturers of culture media are active in North America, which is fuelling the growth of the overall regional market to a large extent.
To understand geography trends, Download Sample Report
The culture media market is moderately competitive with several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies dominating the market are Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Caisson Laboratories Inc., Cell Culture Technologies LLC, Corning Incorporated, Fujifilm Holdings Corporation, GE Healthcare, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, and Merck & Co. Inc.
In January 2021, Captivate Bio launched its portfolio of cell culture tools to assist in the fight against COVID-19 and other emerging diseases.
In May 2020, Chemovator GmbH launched its first product line BIOFLOAT, a type of surface coatings for consumables in cell culture.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Funding for Research and Development
4.2.2 Technological Advancements
4.3 Market Restraints
4.3.1 Stringent Regulatory Issues
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Media Type
5.1.1 Chromogenic Culture Media
5.1.2 Dehydrated Culture Media
5.1.3 Prepared Culture Media
5.2 By End User
5.2.1 Biotechnology and Pharmaceutical Industry
5.2.2 Academic Institute
5.2.3 Other End Users
5.3.1 North America
220.127.116.11 United States
18.104.22.168 United Kingdom
22.214.171.124 Rest of Europe
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
184.108.40.206 South Africa
220.127.116.11 Rest of Middle-East and Africa
5.3.5 South America
18.104.22.168 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Bio-Rad Laboratories Inc.
6.1.4 Caisson Laboratories Inc.
6.1.5 Cell Culture Technologies LLC
6.1.6 CellGenix GmbH
6.1.7 Corning Incorporated
6.1.8 Fujifilm Holdings Corporation
6.1.9 GE Healthcare
6.1.10 HiMedia Laboratories Pvt. Ltd
6.1.11 Lonza Group Ltd
6.1.12 Merck & Co. Inc.
6.1.13 Sartorius AG
6.1.14 Sekisui XenoTech LLC
6.1.15 Thermo Fisher Scientific
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Culture Media Market market is studied from 2018 - 2026.
What is the growth rate of Global Culture Media Market?
The Global Culture Media Market is growing at a CAGR of 6.5% over the next 5 years.
Which region has highest growth rate in Global Culture Media Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Culture Media Market?
North America holds highest share in 2020.
Who are the key players in Global Culture Media Market?
Becton, Dickinson and Company, Fujifilm Holdings Corporation, Corning Incorporated, GE Healthcare, Caisson Laboratories, Inc. are the major companies operating in Global Culture Media Market.